Target intelligence / Profile preview

Retinitis pigmentosa 1 protein (RP1)

Target
RP1
Molecular classification
Microtubule-associated protein, Doublecortin family, Structural protein, Other
01

Overview

Retinitis pigmentosa 1 protein (RP1) is a photoreceptor-specific, microtubule-associated protein encoded by the RP1 gene, a member of the doublecortin family[1][5][6]. It binds microtubules through its N-terminal doublecortin domains, regulating microtubule polymerization and stabilizing the axoneme structure of photoreceptor cells in the retina[1][3][5][6]. RP1 is essential for the correct stacking of outer segment discs and the morphogenesis of rod and cone photoreceptors, maintaining retinal function and visual capacity[1][4][6]. Mutations in RP1 disrupt these processes, causing autosomal dominant and autosomal recessive forms of retinitis pigmentosa characterized by progressive degeneration of photoreceptor cells and visual impairment[2][4][6]. RP1 mutations are a significant cause of hereditary retinal dystrophy, and dysfunction of this protein links retinal degeneration to the wider class of microtubule-associated protein-related neurodegenerative disorders[6]. RP1 is not a traditional small molecule therapeutic target (such as a receptor or enzyme), nor are there known drugs that directly interact with it for clinical intervention[5][6].

Other names
Oxygen-regulated protein 1ORP1DCDC4ADoublecortin domain-containing 4ARetinitis pigmentosa RP1 proteinRetinitis pigmentosa 1 (autosomal dominant)RP1 axonemal microtubule associated
02

Biological functions

Regulation of microtubule polymerizationStabilization of the photoreceptor axonemeStructural integrity and morphogenesis of photoreceptor outer segmentsMaintenance of retinal photoreceptor structure
03

Disease associations

Neurodegenerative diseaseRetinal degenerationRetinitis pigmentosa (autosomal dominant and autosomal recessive)Other
04

Biomarkers

Mutations in RP1 as a genetic biomarker for retinitis pigmentosa diagnosis

Beyond the preview

Go deeper on Retinitis pigmentosa 1 protein (RP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinitis pigmentosa 1 protein (RP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call